Dr. Eberling received her PhD from the University of California at Berkeley and did her post-doctoral training in PET imaging at the Lawrence Berkeley National Laboratory. Prior to joining the Michael J. Fox Foundation in 2009, she did research using PET imaging to study Alzheimer’s disease and Parkinson’s disease, and was involved in the development and translation of gene therapy approaches for Parkinson’s disease. She now leads the imaging program at the Michael J. Fox Foundation and is responsible for efforts to develop novel PET tracers for Parkinson’s disease, including an alpha-synuclein PET tracer.